Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Sale of product	$ 3,169,233	$ 3,112,165	$ 6,073,691	$ 6,201,700
Cost of product	1,151,722	1,269,552	2,190,069	2,579,051
Gross profit	2,017,511	1,842,613	3,883,622	3,622,649
Operating costs and expenses:
Salaries and contract labor	961,842	944,179	1,902,345	1,919,361
General, administrative and consulting	1,047,063	943,870	2,050,620	1,771,852
Research and development	188,730	183,024	376,977	307,468
Total operating expenses	2,197,635	2,071,073	4,329,942	3,998,681
Net operating loss	(180,124)	(228,460)	(446,320)	(376,032)
Other income (expense):
Other income	(5,344)	37,518	155,376	100,930
Interest income	33,531	9,856	66,259	28,942
Interest expense	(81,508)	(82,216)	(162,811)	(165,196)
Total other income (expense)	(53,321)	(34,842)	58,824	(35,324)
Net Loss	$ (233,445)	$ (263,302)	$ (387,496)	$ (411,356)
Net loss per common share - basic: (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Net loss per common share - diluted: (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Weighted average common shares outstanding - basic (in shares)	522,779,643	517,926,610	521,473,413	516,746,718
Weighted average common shares outstanding - diluted (in shares)	522,779,643	517,926,610	521,473,413	516,746,718